The RBMS2 Antibody (PACO35322) is a high-quality polyclonal antibody designed for research studies involving RBMS2, a RNA-binding protein known to be involved in post-transcriptional regulation of gene expression. This antibody is produced in rabbits and has been validated for use in various applications, including Western blot and immunohistochemistry.RBMS2, also known as RNA-binding motif, single-stranded interacting protein 2, is a key player in the regulation of mRNA stability and translation. It is believed to be involved in a wide range of cellular processes, including cell growth, differentiation, and apoptosis.
The RBMS2 Antibody specifically targets the RBMS2 protein, allowing for accurate detection and analysis in different cell types and tissues.Research into RBMS2 has shown its potential importance in diseases such as cancer, neurodegenerative disorders, and cardiovascular diseases. Understanding the role of RBMS2 in these conditions could lead to the development of new therapeutic approaches targeting this RNA-binding protein. By utilizing the RBMS2 Antibody, researchers can further explore the function and regulation of RBMS2 in various biological contexts.
Western blot. All lanes: RBMS2 antibody at 0.5µg/ml + MCF-7 whole cell lysate. Secondary. Goat polyclonal to rabbit IgG at 1/10000 dilution. Predicted band size: 44 kDa. Observed band size: 44 kDa.
Immunohistochemistry of paraffin-embedded human cervical cancer using PACO35322 at dilution of 1:100.
Immunohistochemistry of paraffin-embedded human adrenal gland tissue using PACO35322 at dilution of 1:100.
Synonyms:
RNA-binding motif, single-stranded-interacting protein 2 (Suppressor of CDC2 with RNA-binding motif 3), RBMS2, SCR3
